Cardioselective infection with coxsackievirus B3 requires intact type I interferon signaling: implications for mortality and early viral replication
- PMID: 11156890
- DOI: 10.1161/01.cir.103.5.756
Cardioselective infection with coxsackievirus B3 requires intact type I interferon signaling: implications for mortality and early viral replication
Abstract
Background: Interferons (IFNs) play an important role in antiviral defense and have therapeutic potential in coxsackievirus heart disease. However, little is known about the relative contributions of type I and type II IFN signaling in coxsackievirus B3 (CVB3) infection or their role in the cardioselective nature of CVB3 infection.
Methods and results: Wild-type mice and mice deficient for either the type I or the type II IFN receptor (IFNR) were infected with CVB3. Infection of the type I IFNR-deficient mice with >10(3) plaque-forming units (pfu) of CVB3 resulted in 100% mortality within 2 to 4 days after infection. Death was rare in wild-type and type II IFNR-deficient mice after inoculation with as much as 10(8) pfu of CVB3. Surprisingly, the early mortality in the type I IFNR-deficient mice was not accompanied by higher virus titers in the heart. Unexpectedly, a dramatic increase of viral RNA in the liver was found to correlate with early mortality in type I IFNR-deficient mice.
Conclusions: Type I but not type II IFN signaling is essential for the prevention of early death due to CVB3 infection. Interestingly, neither type I or type II IFN signaling has a dramatic effect on early viral replication in the heart. However, lethal viral replication in the liver is controlled by type I IFNs. These results demonstrate that the IFN system is capable of modulating both viral pathogenicity and tissue tropism.
Similar articles
-
TRIM21 Restricts Coxsackievirus B3 Replication, Cardiac and Pancreatic Injury via Interacting With MAVS and Positively Regulating IRF3-Mediated Type-I Interferon Production.Front Immunol. 2018 Oct 25;9:2479. doi: 10.3389/fimmu.2018.02479. eCollection 2018. Front Immunol. 2018. PMID: 30410495 Free PMC article.
-
Interferon-beta expression and type I interferon receptor signaling of hepatocytes prevent hepatic necrosis and virus dissemination in Coxsackievirus B3-infected mice.PLoS Pathog. 2018 Aug 3;14(8):e1007235. doi: 10.1371/journal.ppat.1007235. eCollection 2018 Aug. PLoS Pathog. 2018. PMID: 30075026 Free PMC article.
-
Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.J Virol. 2015 Oct;89(20):10512-23. doi: 10.1128/JVI.01028-15. Epub 2015 Aug 12. J Virol. 2015. PMID: 26269170 Free PMC article.
-
Recombinant coxsackievirus vectors for prevention and therapy of virus-induced heart disease.Int J Med Microbiol. 2008 Jan;298(1-2):127-34. doi: 10.1016/j.ijmm.2007.08.010. Epub 2007 Sep 25. Int J Med Microbiol. 2008. PMID: 17897883 Review.
-
Genetics of coxsackievirus virulence.Curr Top Microbiol Immunol. 1997;223:227-58. doi: 10.1007/978-3-642-60687-8_11. Curr Top Microbiol Immunol. 1997. PMID: 9294932 Review. No abstract available.
Cited by
-
Viral infections in humans and mice with genetic deficiencies of the type I IFN response pathway.Eur J Immunol. 2021 May;51(5):1039-1061. doi: 10.1002/eji.202048793. Epub 2021 Apr 4. Eur J Immunol. 2021. PMID: 33729549 Free PMC article. Review.
-
Autoimmune myocarditis, valvulitis, and cardiomyopathy.Curr Protoc Immunol. 2013;Chapter 15:Unit 15.14.1-51. doi: 10.1002/0471142735.im1514s101. Curr Protoc Immunol. 2013. PMID: 23564686 Free PMC article.
-
Sex-specific signaling through Toll-Like Receptors 2 and 4 contributes to survival outcome of Coxsackievirus B3 infection in C57Bl/6 mice.Biol Sex Differ. 2012 Dec 15;3(1):25. doi: 10.1186/2042-6410-3-25. Biol Sex Differ. 2012. PMID: 23241283 Free PMC article.
-
Cell type-specific roles of PAR1 in Coxsackievirus B3 infection.Sci Rep. 2021 Jul 12;11(1):14264. doi: 10.1038/s41598-021-93759-8. Sci Rep. 2021. PMID: 34253819 Free PMC article.
-
The impact of juvenile coxsackievirus infection on cardiac progenitor cells and postnatal heart development.PLoS Pathog. 2014 Jul 31;10(7):e1004249. doi: 10.1371/journal.ppat.1004249. eCollection 2014 Jul. PLoS Pathog. 2014. PMID: 25079373 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources